Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men
暂无分享,去创建一个
Yoshiro Sugita | Makoto Nishida | M. Nishida | Y. Sugita | T. Moriyama | K. Yamauchi-Takihara | Toshiki Moriyama | Keiko Yamauchi-Takihara
[1] B. Nicklas,et al. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. , 2004, The Journal of clinical endocrinology and metabolism.
[2] Philipp E. Scherer,et al. Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans , 2007, Diabetes.
[3] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[4] H. Brenner,et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.
[5] Y. Matsuzawa. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.
[6] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[7] Eiji Oda,et al. New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[8] M. Reilly,et al. The Metabolic Syndrome: More Than the Sum of Its Parts? , 2003, Circulation.
[9] N. Sattar,et al. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians , 2001, International Journal of Obesity.
[10] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[11] S. B. Pedersen,et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.
[12] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[13] T. Funahashi,et al. Pathophysiological significance of adiponectin , 2007, Medical Molecular Morphology.
[14] S. Kihara,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[15] Takahisa Kondo,et al. Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[16] H. Yatsuya,et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state , 2003, International Journal of Obesity.
[17] Jane B Shofer,et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.
[18] E. Oda. New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[19] S. Kihara,et al. Adiponectin as a biomarker of the metabolic syndrome. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[20] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[21] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[22] E. Ford,et al. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.
[23] Y. Shima,et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. , 2000, Blood.
[24] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[25] A. Aljada,et al. Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .
[26] M. Nishida,et al. Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[27] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.
[28] J. Després,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[29] Hitoshi Nishizawa,et al. Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue , 2003, Circulation.